Ledger.Open graph →
SEC Form D · filed April 22, 2020

Oricula Therapeutics LLC

Offering
$500K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Malcolm Gleser · Seattle, WAExec · Director · PromoterVince Groppi · Seattle, WADirector · PromoterEd Rubel · Seattle, WADirector · PromoterDouglas J. Tkach · Winnipeg, Manitoba, CanadaExec · Director · PromoterPaul R. Desmarais · Winnipeg, Manitoba, CanadaDirector · PromoterS. M. Corbett · Winnipeg, Manitoba, CanadaDirector · PromoterJames M. Singh · Winnipeg, Manitoba, CanadaDirector · PromoterEmoke J. Szathmary · Winnipeg, Manitoba, CanadaDirector · PromoterGraham R. Bird · Winnipeg, Manitoba, CanadaExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗